Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Feb;58(2):540-549.
doi: 10.1002/ppul.26225. Epub 2022 Nov 11.

Inherited pulmonary surfactant metabolism disorders in Argentina: Differences between patients with SFTPC and ABCA3 variants

Juan E Balinotti  1   2 , Camila Mallie  1 , Alberto Maffey  1 , Alejandro Colom  1 , Ralph Epaud  3 , Alix de Becdelievre  4 , Pascale Fanen  4 , Céline Delestrain  3 , Martín Medín  5 , Alejandro Teper  1
Affiliations
Free article
Observational Study

Inherited pulmonary surfactant metabolism disorders in Argentina: Differences between patients with SFTPC and ABCA3 variants

Juan E Balinotti et al. Pediatr Pulmonol. 2023 Feb.
Free article

Abstract

Background: Patients with inherited pulmonary surfactant metabolism disorders have a wide range of clinical outcomes and imaging findings. Response to current anti-inflammatory therapies has been variable and efficacy is unclear.

Objective: To describe and compare genetic, clinical, histological, and computed tomography (CT) outcomes in a cohort of patients with variants in the genes encoding surfactant protein C (SP-C) or adenosine triphosphate-binding cassette transporter A3 (ABCA3) in Argentina.

Methods: Observational cohort retrospective study. Patients carrying variants in genes encoding SP-C and ABCA3 proteins were included.

Results: Fourteen patients met the inclusion criteria: SFTPC n = 6, ABCA3 n = 8 (seven were heterozygous and one compound heterozygous). Neonatal respiratory distress was more frequent and severe in neonates with variants in the ABCA3 gene. The onset of the disease occurred in infancy before the age of 20 months in all cases. Patients with ABCA3 pathogenic variants had a severe clinical course, while long-term outcomes were more favorable in individuals with SFTPC variants. Initial CT findings were ground glass opacities and intraparenchymal cysts in both groups. Over time, signs of lung fibrosis were present in 57% of patients with ABCA3 variants and in 33% of the SFTPC group. The efficacy of anti-inflammatory interventions appears to be poor, especially for patients with ABCA3 pathogenic variants.

Conclusions: Clinical, histological, and radiological features are similar in patients with SFTPC and ABCA3 variants; however, the latter have more severe clinical course. Current anti-inflammatory regimens do not appear to stop the progression of the disease.

Keywords: ABCA3 deficiency; interstitial lung disease; pulmonary surfactant; pulmonary surfactant protein C.

PubMed Disclaimer

References

REFERENCES

    1. Kurland G, Deterding RR, Hagood JS, et al. An official American thoracic society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med. 2013;188:376-394.
    1. Gower WA, Nogee LM. Surfactant dysfunction. Paediatr Respir Rev. 2011;12(4):223-229.
    1. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol. 2009;12(4):253-274.
    1. Weaver TE. Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta - Mol Basis Dis. 1998;1408(2-3):173-179.
    1. Perez-Gil J, Weaver TE. Pulmonary surfactant pathophysiology: current models and open questions. Physiology. 2010;25(3):132-141.

Publication types

Substances